In Vitro and in Vivo Efficacy of Afatinib as a Single Agent or in Combination With Gemcitabine for The treatment of Nasopharyngeal Carcinoma
Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s94432
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2016
Authors
Publisher
Informa UK Limited